S4-E20.4 - Donna Cryer’s Call to Action for Patient Advocacy in the NASH Community
Send us Fan Mail Donna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing needs across all Fatty Liver stakeholders. The...
14 Maj 20238min
S4-E20.3 - Generating and Promoting the Data to Demonstrate Patient Needs
Send us Fan Mail Donna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing needs across all Fatty Liver stakeholders. The...
13 Maj 202312min
S4-E20.2 - Listening to Both Sides: Allied Health for Patient Empowerment
Send us Fan Mail Donna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing needs across all Fatty Liver stakeholders. The...
13 Maj 202312min
S4-E20.1 - Who is going to be the Larry Kramer of NASH?
Send us Fan Mail Donna Cryer joins Jörn Schattenberg, Louise Campbell and Roger Green for an impactful episode which weighs the complexities of competing needs across all Fatty Liver stakeholders. The...
13 Maj 202312min
S4-E20 - Leveraging Patient Voice and Needs in the NASH Community
Send us Fan Mail This week, Donna Cryer (Global Liver Institute) joins Jörn Schattenberg, Louise Campbell and Roger Green for an impassioned and sobering episode which weighs the complexities of compe...
11 Maj 202355min
S4-E19.6 - From the Vault: REGENERATE Redux: Clearing The Finish Line?
Send us Fan Mail On July 7 2022, Intercept Pharmaceuticals released new results from the continuation of the REGENERATE trial and announced their intent to file a new NDA for obeticholic acid (OCA) in...
7 Maj 202313min
S4-E19.5 - Teasing the Difference Between Patient Advocate Voice and Patient Advocate Vote
Send us Fan Mail Back in March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. The Surfers d...
7 Maj 202310min
S4-E19.4 - Patient Advocates Describe the Reasoning Behind Their Testimonies
Send us Fan Mail Back in March 2023, Jeff McIntyre (GLI) introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. The Surfers d...
7 Maj 202311min
